IDO1 and neoplasm: Here, using a proteomic-based approach, we show that the kynurenine pathway is more broadly disrupted than has been previously considered, extending beyond IDO1, that this is a common event in RCC and is not just restricted to the clear cell histological subtype and suggests possible redundancy in the pathway within the tumour setting.